IFM Therapeutics

📍 Boston, United States🗓 Founded 2017👥 17 employees💰 Last funded Nov 2019
At IFM Therapeutics, we work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body’s first line of immunological response and an essential component of immune function.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in IFM Therapeutics?
IFM Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did IFM Therapeutics last raise funding?
The most recent investment in IFM Therapeutics recorded on gritt.io was in November 2019.
When was IFM Therapeutics founded?
IFM Therapeutics was founded in 2017.
What industry is IFM Therapeutics in?
IFM Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is IFM Therapeutics based?
IFM Therapeutics is headquartered in Boston, United States.